This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ETFs to Play the Reopening Trade as Omicron Fear Subsides
by Sweta Jaiswal, FRM
The improved market sentiments have been leading to greater attention and confidence in reopening trades.
Why Reopening-Friendly ETFs Can be Bought on the Dip?
by Sanghamitra Saha
Omicron is believed to be less severe than Delta by some experts while President Biden is not planning to impose lockdown now. With economies and citizens having learnt to deal with COVID variants in the past two years, fresh global shutdown is less likely.
ETFs to Suffer as US Consumer Confidence Falls to a 9-Month Low
by Sweta Jaiswal, FRM
U.S. consumer confidence takes a hit in November from the rising concerns over surging inflationary levels.
ETFs to Suffer as US Consumer Sentiment Slips to 10-Year-Low Mark
by Sweta Jaiswal, FRM
The U.S. consumer sentiment takes a hit in November from the rising concerns over surging inflationary levels.
Will ETFs Suffer as US Consumer Sentiment Slips in November?
by Sweta Jaiswal, FRM
The U.S. consumer sentiment takes a hit in early November from the rising concerns over surging inflationary levels.
Consumer Discretionary ETFs to Gain as COVID-19 Situation Improves
by Sweta Jaiswal, FRM
The recovering U.S. economy, lifting travel restrictions, improving COVID-19 situation and progress in coronavirus vaccine rollout are expected to drive investors toward the consumer discretionary sector.
How Are ETFs Reacting to Starbucks' Q4 Earnings Results?
by Sweta Jaiswal, FRM
Starbucks' (SBUX) Q4 earnings release looks decent as earnings results met expectations.
ETFs to Gain as US Consumer Confidence Rises in October
by Sweta Jaiswal, FRM
The rise in consumer confidence on easing Delta variant concerns and improving labor market conditions might help the consumer discretionary sector, which attracts a major portion of consumer spending.
ETFs in Focus Post Dismal Amazon Q3 Results
by Sweta Killa
Amazon missed revenue and earnings estimates, and offered weak fourth-quarter guidance.
5 Consumer Discretionary ETFs Rising to New Highs
by Sweta Killa
With the economy regaining momentum after a pandemic slowdown buoyed by the biggest vaccination drive and reopenings, the consumer discretionary sector looks like an exciting bet at present.
Will ETFs Suffer as US Consumer Sentiment Falls in October?
by Sweta Jaiswal, FRM
The U.S. consumer sentiment takes a hit in early October from the rising concerns over surging coronavirus cases and inflationary levels.
Should You Invest in the Fidelity MSCI Consumer Discretionary Index ETF (FDIS)?
by Zacks Equity Research
Sector ETF report for FDIS
5 Top-Ranked ETFs Looking Good Following the September Slump
by Sweta Jaiswal, FRM
Take a look at some top-ranked ETFs that might help strengthen your portfolio and rake in some good returns.
ETFs to Play the Reopening Trade on Merck's Oral Antiviral Pill News
by Sweta Jaiswal, FRM
Let's take a look at ETFs that are well-poised to gain as the reopening of the U.S. economy may pick up further pace following Merck's announcement.
ETFs to Suffer as US Consumer Confidence Falls in September
by Sweta Jaiswal, FRM
The fall in consumer confidence is likely to hurt the consumer discretionary sector which attracts a major portion of consumer spending.
Can Consumer Discretionary ETFs Make Good Bets for Q4?
by Sweta Jaiswal, FRM
The recovering U.S. economy and progress in coronavirus vaccine rollout are expected to increasingly drive investors toward the consumer discretionary sector.
Should You Invest in the Fidelity MSCI Consumer Discretionary Index ETF (FDIS)?
by Zacks Equity Research
Sector ETF report for FDIS
Will ETFs Gain as US Consumer Sentiment Improves in September?
by Sweta Jaiswal, FRM
The U.S. consumer sentiment slightly improved in early-September amid rising concerns about surging coronavirus cases and inflationary levels.
ETFs to Suffer as US Consumer Confidence Falls in August
by Sweta Jaiswal, FRM
The fall in consumer confidence is likely to hurt the consumer discretionary sector, which attracts a major portion of consumer spending.
ETFs to Rise on Full FDA Approval for Pfizer COVID-19 Vaccine
by Sweta Jaiswal, FRM
Let's look at the ETFs that are well-poised to gain as Comirnaty's full FDA approval is likely to drive the vaccination rate.
Should You Invest in the Fidelity MSCI Consumer Discretionary Index ETF (FDIS)?
by Zacks Equity Research
Sector ETF report for FDIS
The Zacks Analyst Blog Highlights: FDIS, KRE, DGRO, FMAT and XLV
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FDIS, KRE, DGRO, FMAT and XLV
5 Top-Ranked ETFs Looking Good After a Decent July
by Sweta Jaiswal, FRM
Here we discuss some top-ranked ETFs that seem like a good addition to the portfolio considering the present market scenario largely dominated by delta variant concerns.
Amazon Q2 Earnings Disappoint: ETFs in Focus
by Sweta Killa
Amazon missed revenue estimates for the first time in three quarters and offered weak third-quarter guidance though it beat on the bottom line.
Will ETFs Gain on Starbucks' Q3 Earnings Beat Amid Pandemic?
by Sweta Jaiswal, FRM
Starbucks' Q3 earnings release looks encouraging on better-than-expected earnings results amid the coronavirus crisis.